API GMP
Good Manufacturing Practice for Active Pharmaceutical Ingredients (ICH Q7)
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
The discipline and harmonized guideline setting good manufacturing practice expectations specifically for active pharmaceutical ingredient manufacturing — from starting material through the final API isolation and packaging steps — recognizing that API synthesis differs structurally from finished dosage-form manufacturing and needs its own scope and controls.
ICH Q7 sets out GMP expectations tailored to chemical and, in part, biotechnological API manufacture: quality unit responsibilities, building and facility controls, equipment qualification, materials management, production and process controls, and impurity/quality control specific to intermediates and APIs rather than finished dosage forms.
A defining feature of API GMP is the concept of increasing GMP stringency as the process moves from early synthetic steps toward the final API isolation, purification, and packaging steps — early intermediates are subject to lighter controls than the final API, reflecting the point in synthesis where impurities are most consequential to final product quality.
API GMP is distinct from finished-product GMP requirements such as 21 CFR 211: ICH Q7 has been adopted by FDA as guidance and incorporated into EU GMP as Part II of EudraLex Volume 4, giving it harmonized status across the major regulatory regions covered by ICH.
- —Scoped specifically to API manufacture, distinct from finished-dosage-form GMP
- —Applies increasing GMP stringency as synthesis approaches the final API isolation step
- —Adopted by FDA as guidance and by the EU as EudraLex Volume 4, Part II
- —Covers starting materials, intermediates, and the final API through packaging
ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (2000); EudraLex Volume 4, Part II
Frequently asked questions
What does API GMP stand for?
API GMP stands for Good Manufacturing Practice for Active Pharmaceutical Ingredients (ICH Q7).
What is API GMP?
The discipline and harmonized guideline setting good manufacturing practice expectations specifically for active pharmaceutical ingredient manufacturing — from starting material through the final API isolation and packaging steps — recognizing that API synthesis differs structurally from finished dosage-form manufacturing and needs its own scope and controls.
Which regulations cover API GMP?
ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (2000); EudraLex Volume 4, Part II